Key Insights

Highlights

Success Rate

50% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 65/100

Termination Rate

25.0%

1 terminated out of 4 trials

Success Rate

50.0%

-36.5% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

200%

2 of 1 completed with results

Key Signals

2 with results50% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (3)
P 4 (1)

Trial Status

Completed1
Not Yet Recruiting1
Terminated1
Unknown1

Trial Success Rate

50.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (4)

Research Network

Activity Timeline